Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF.

MLA

Voordes, Geert, et al. “Biologically Active Adrenomedullin as a Marker for Residual Congestion and Early Rehospitalization in Patients Hospitalized for Acute Heart Failure: Data from STRONG-HF.” European Journal of Heart Failure, vol. 26, no. 7, July 2024, pp. 1480–92. EBSCOhost, https://doi.org/10.1002/ejhf.3336.

APA

Voordes, G., Davison, B., Biegus, J., Edwards, C., Damman, K., Ter Maaten, J., Mebazaa, A., Takagi, K., Adamo, M., Ambrosy, A. P., Arrigo, M., Barros, M., Celutkiene, J., Čerlinskaitė-Bajorė, K., Chioncel, O., Cohen-Solal, A., Damasceno, A., Deniau, B., Diaz, R., … Voors, A. A. (2024). Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF. European Journal of Heart Failure, 26(7), 1480–1492. https://doi.org/10.1002/ejhf.3336

Chicago

Voordes, Geert, Beth Davison, Jan Biegus, Christopher Edwards, Kevin Damman, Jozine Ter Maaten, Alexandre Mebazaa, et al. 2024. “Biologically Active Adrenomedullin as a Marker for Residual Congestion and Early Rehospitalization in Patients Hospitalized for Acute Heart Failure: Data from STRONG-HF.” European Journal of Heart Failure 26 (7): 1480–92. doi:10.1002/ejhf.3336.